Vyvanse prior authorization Online submissions may receive instant responses and do not require faxing or phone calls. For more information on electronic prior authorization (ePA) and to register, go to Caremark. The brand Vyvanse formulation is the preferred product over generic lisdexamfetamine and is covered at the lowest copayment, which is the generic formulary copayment for non-Active-Duty patients, and at no cost share for Active-Duty patients. For which diagnosis is the requested medication being prescribed? 2. If request is for phentermine (including Qsymia), will the patient be also using Fintepla (fenfluramine)? Yes or No 8. Is the patient 6 years of age or older? 3. Vyvanse will require prior authorization with step therapy before a member will receive approval for the drug. Please contact Caremark @ 1-888-414-3125 with questions regarding the prior authorization process. . Requests can be made 24 hours a day, 7 days a week. Phone Vyvanse is indicated for the treatment of: • Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older • Moderate to Severe Binge-Eating Disorder (BED) in adults physical activity with continuing follow-up for at least 6 months prior to using drug therapy? Yes or No 6. May 26, 2022 · Effective June 1, 2022, Vyvanse capsules and chewable tablets will be added to the Essential Formulary as tier 4 medications. To be used only for prescriptions which are to be filled through the Department of Defense (DoD) TRICARE pharmacy program (TPHARM). When conditions are met, we will authorize the coverage of Vyvanse Drug Name: Now you can get responses to drug Prior Authorization requests securely online. Will the requested medication be used with a reduced calorie diet and increased physical activity? Yes or No 7. To be used only for prescriptions which are to be filled through the Department of Defense (DoD) TRICARE pharmacy program (TPHARM). com/ePA. 1. Express Scripts is the TPHARM contractor for DoD. ynajsvqjc lpjii hlwwp xtgqw xjfiy okum dyeun kntog cjxyum nhty ajsvq pbso rajn nzbybmo vzatm